MEDIFAST INC (MED) to Release Quarterly Earnings on Tuesday

MEDIFAST INC (NYSE:MED) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, August 8th. Analysts expect MEDIFAST INC to post earnings of $0.53 per share for the quarter. MEDIFAST INC has set its Q2 guidance at $0.51-0.54 EPS and its FY17 guidance at $2.00-2.10 EPS.

Receive News & Ratings for MEDIFAST INC Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDIFAST INC and related companies with MarketBeat.com's FREE daily email newsletter.

MEDIFAST INC (NYSE:MED) last released its quarterly earnings data on Thursday, May 4th. The specialty retailer reported $0.51 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.49 by $0.02. MEDIFAST INC had a return on equity of 24.94% and a net margin of 7.23%. The business had revenue of $70.62 million for the quarter, compared to the consensus estimate of $72.36 million. During the same quarter in the previous year, the company posted $0.42 EPS. The company’s revenue was down 2.4% compared to the same quarter last year. On average, analysts expect MEDIFAST INC to post $2.05 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Shares of MEDIFAST INC (NYSE MED) opened at 42.69 on Tuesday. The company has a market cap of $509.16 million, a P/E ratio of 26.03 and a beta of 0.50. The firm has a 50-day moving average price of $41.66 and a 200-day moving average price of $43.11. MEDIFAST INC has a 1-year low of $34.64 and a 1-year high of $47.35.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, August 9th. Shareholders of record on Friday, June 23rd will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Wednesday, June 21st. This represents a $1.28 dividend on an annualized basis and a yield of 3.00%. MEDIFAST INC’s dividend payout ratio is currently 77.58%.

WARNING: “[[title]]” was originally posted by [[site]] and is owned by of [[site]]. If you are viewing this article on another domain, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this article can be accessed at [[permalink]].

Separately, Sidoti downgraded MEDIFAST INC from a “buy” rating to a “neutral” rating in a research report on Tuesday, May 2nd.

About MEDIFAST INC

Medifast, Inc is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins.